// App-Quantinova.ai

628 : IL-2 augments immTAC-dependent T cell activation and tumour cell killing

Researchers

Presenter

  • Duncan Gascoyne

Principal Investigators

  • Kristina Petrovic

  • Koustubh Ranade

  • David Depoil

Medical Centers

  • Immunocore Ldt, Oxford, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

  • Uveal melanoma

  • Melanoma

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Glycoprotein 100

  • Interleukin-2

Drug/Treatment

  • Aldesleukin

  • GP100

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved